Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O F Wagner

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Medicine|August 8, 2025
FGFR4 p.Gly388Arg polymorphism in PBMCs of LAM patients: findings of a pilot studySinem Koc-Gunel, Amy L Ryan, Melanie Winter, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1987
Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodiesJ Wojta, L Turcu, O F Wagner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosisN Dauletbaev, K Viel, R Buhl, et al.
Studies in Health Technology and Informatics|April 22, 2018
Conception of an Expert Advisory Board for the European Reference Network for Rare Respiratory DiseasesDésirée Walther, Olivia Steinmann, Johanna Schaefer, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitusA Kautzky-Willer, P Fasching, B Jilma, et al.
European Journal of Clinical Investigation|March 15, 2008
Classification of chronic kidney disease by estimated glomerular filtration rateC Marsik, G Endler, T Gulesserian, et al.
The Journal of Clinical Investigation|August 1, 1989
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PAO F Wagner, C de Vries, C Hohmann, et al.
Studies in Health Technology and Informatics|April 22, 2018
Mapping of Health Care Providers for People with Rare Diseases - From Vision to ImplementationJohanna Schaefer, Niels Tegtbauer, Wulf Pfeiffer, et al.
British Journal of Haematology|August 25, 1999
Circadian variation of granulocyte colony stimulating factor levels in manB Jilma, N Hergovich, P Stohlawetz, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 15, 2017
[Registries for rare diseases : OSSE - An open-source framework for technical implementation]Holger Storf, Jannik Schaaf, Dennis Kadioglu, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Medicine|August 8, 2025
FGFR4 p.Gly388Arg polymorphism in PBMCs of LAM patients: findings of a pilot studySinem Koc-Gunel, Amy L Ryan, Melanie Winter, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1987
Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodiesJ Wojta, L Turcu, O F Wagner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosisN Dauletbaev, K Viel, R Buhl, et al.
Studies in Health Technology and Informatics|April 22, 2018
Conception of an Expert Advisory Board for the European Reference Network for Rare Respiratory DiseasesDésirée Walther, Olivia Steinmann, Johanna Schaefer, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitusA Kautzky-Willer, P Fasching, B Jilma, et al.
European Journal of Clinical Investigation|March 15, 2008
Classification of chronic kidney disease by estimated glomerular filtration rateC Marsik, G Endler, T Gulesserian, et al.
The Journal of Clinical Investigation|August 1, 1989
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PAO F Wagner, C de Vries, C Hohmann, et al.
Studies in Health Technology and Informatics|April 22, 2018
Mapping of Health Care Providers for People with Rare Diseases - From Vision to ImplementationJohanna Schaefer, Niels Tegtbauer, Wulf Pfeiffer, et al.
British Journal of Haematology|August 25, 1999
Circadian variation of granulocyte colony stimulating factor levels in manB Jilma, N Hergovich, P Stohlawetz, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 15, 2017
[Registries for rare diseases : OSSE - An open-source framework for technical implementation]Holger Storf, Jannik Schaaf, Dennis Kadioglu, et al.
Pageof 10